Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Toxicon : Official Journal of the International Society on Toxinology|November 18, 2019
Characterization of microcystin-induced apoptosis in HepG2 hepatoma cellsAnjali Krishnan, Gary Koski, Xiaozhen MouJournal of Immunology Research|May 2, 2017
LEAPS Vaccine Incorporating HER-2/neu Epitope Elicits Protection That Prevents and Limits Tumor Growth and Spread of Breast Cancer in a Mouse ModelKen S Rosenthal, Sarah Stone, Gary Koski, et al.Head & Neck|January 8, 2010
Immunotherapy using allogeneic squamous cell tumor-dendritic cell fusion hybridsWalter T Lee, Chunrui Tan, Gary Koski, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonistsRobert E Roses, Shuwen Xu, Min Xu, et al.Surgery|August 15, 2006
High-avidity antitumor T-cell generation by toll receptor 8-primed, myeloid- derived dendritic cells is mediated by IL-12 productionShuwen Xu, Ursula Koldovsky, Min Xu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patientsIsabelle Bedrosian, Rosemarie Mick, Shuwen Xu, et al.Frontiers in Immunology|May 20, 2021
Differentiation and Regulation of T<sub>H</sub> Cells: A Balancing Act for Cancer ImmunotherapyAmrita Basu, Ganesan Ramamoorthi, Gabriella Albert, et al.Cancer|January 19, 2012
HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situAnupama Sharma, Ursula Koldovsky, Shuwen Xu, et al.Journal for Immunotherapy of Cancer|June 16, 2022
Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinomaGanesan Ramamoorthi, Krithika Kodumudi, Colin Snyder, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 7, 2021
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathwayYongsheng Jia, Krithika N Kodumudi, Ganesan Ramamoorthi, et al.Pageof 1